• British Pharmacopoeia Volume I & II
  • Monographs: Medicinal and Pharmaceutical Substances

Tetryzoline Hydrochloride

European Union chaplet of stars
scroll to previous hit
scroll to next hit
General Notices

(Ph Eur monograph 2101)

bp2010_v2_08_monographs_medicinal_and_pharmaceutical_substances tetryzolinehydrochloride_1_2009_60_cs.png


C13H17ClN2    236.7    522-48-5

Action and use

Adrenoceptor agonist; decongestant.

Ph Eur

DEFINITION

2-[(1RS)-1,2,3,4-Tetrahydronaphthalen-1-yl]-4,5-dihydro-1H-imidazole hydrochloride.

Content

98.0 per cent to 101.0 per cent (dried substance).

CHARACTERS
Appearance

White or almost white, crystalline powder.

Solubility

Freely soluble in water, in anhydrous ethanol and in ethanol (96 per cent), practically insoluble in acetone.

IDENTIFICATION

A.  Infrared absorption spectrophotometry (2.2.24).

Comparison  tetryzoline hydrochloride CRS.

B.  Dissolve 50 mg in 10 ml of water R. The solution gives reaction (a) of chlorides (2.3.1).

TESTS
Appearance of solution.

The solution is clear (2.2.1) and colourless (2.2.2, Method II).

Dissolve 1.0 g in water R and dilute to 10 ml with the same solvent.

Related substances

Gas chromatography (2.2.28).

Test solution  Dissolve 1.0 g of the substance to be examined in a mixture of 25 volumes of 1 M sodium hydroxide and 75 volumes of methanol R and dilute to 10 ml with the same mixture of solvents.

Reference solution  Dilute 1.0 ml of the test solution to 100.0 ml with a mixture of 25 volumes of 1 M sodium hydroxide and 75 volumes of methanol R. Dilute 1.0 ml of this solution to 10.0 ml with a mixture of 25 volumes of 1 M sodium hydroxide and 75 volumes of methanol R.

Column:
  • material: fused silica;
  • size: l  =  25 m, Ø = 0.32 mm;

Carrier gas  helium for chromatography R.

Split ratio  1:40.

Flow rate  2.5 ml/min.

Temperature:

bp2010_v2_08_monographs_medicinal_and_pharmaceutical_substances tetryzolinehydrochloride_2_2009_60_tb.png


Detection  Flame ionisation.

Injection  1 µl.

Relative retention  With reference to tetryzoline (retention time  =  about 12 min): impurity A  =  about 0.5.

System suitability  Reference solution:

Limits:
  • impurity A: not more than the area of the principal peak in the chromatogram obtained with the reference solution (0.1 per cent);
  • any other impurity: for each impurity, not more than the area of the principal peak in the chromatogram obtained with the reference solution (0.1 per cent);
  • total: not more than twice the area of the principal peak in the chromatogram obtained with the reference solution (0.2 per cent);
  • disregard limit: 0.5 times the area of the principal peak in the chromatogram obtained with the reference solution (0.05 per cent).

Maximum 0.5 per cent, determined on 1.000 g by drying in an oven at 105 °C.

Maximum 0.1 per cent, determined on 1.0 g.

ASSAY

Dissolve 0.200 g in 100 ml of a mixture of 3 volumes of anhydrous acetic acid R and 7 volumes of acetic anhydride R. Titrate with 0.1 M perchloric acid, determining the end-point potentiometrically (2.2.20). Carry out a blank titration.

1 ml of 0.1 M perchloric acid is equivalent to 23.67 mg of C13H17ClN2.

IMPURITIES

Specified impurities  A.

bp2010_v2_08_monographs_medicinal_and_pharmaceutical_substances tetryzolinehydrochloride_3_2009_60_cs.png


A.  (1RS)-1,2,3,4-tetrahydronaphthalene-1-carbonitrile (α-cyanotetraline).

Ph Eur